Management of moderate pruritus
Renal Dose Adjustment
Hepatic Dose Adjustment
See Supplemental Patient Information
Cautions: Use cautiously in
Supplemental Patient Information
Zonalon interacts with :
Pregnancy Category:B
Breastfeeding: Safety unknown; adverse reactions may occur due to presence of active metabolite in infant serum. Prefer an alternative agent especially while nursing a newborn or preterm infant. May not be a reason to discontinue breastfeeding if doxepin is required by the mother of an older infant; carefully monitor infant for excessive sedation and adequate weight gain. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 17 December 2010). May be excreted in human milk following topical application. Exhibits potential for serious adverse reactions in nursing infants. Manufacturer advises to make decision to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
US Trade Name(s)
US Availability
Zonalon
Canadian Trade Name(s)
Canadian Availability
Zonalon
UK Trade Name(s)
UK Availability
Australian Trade Name(s)
Australian Availability
Pricing data from www.DrugStore.com in U.S.A.
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
